APA (7th ed.) Citation

M, C., KW, M., K, P., Jr, P. C., EM, A., J, H., . . . Investigators, S. T. (2006). A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial Enoxaparin Versus Unfractionated Heparin in Non-ST-Segment Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology (JACC), 48(7), 1346. https://doi.org/10.1016/j.jacc.2006.05.058

Chicago Style (17th ed.) Citation

M, Cohen, et al. "A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial Enoxaparin Versus Unfractionated Heparin in Non-ST-Segment Elevation Acute Coronary Syndromes." Journal of the American College of Cardiology (JACC) 48, no. 7 (2006): 1346. https://doi.org/10.1016/j.jacc.2006.05.058.

MLA (9th ed.) Citation

M, Cohen, et al. "A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial Enoxaparin Versus Unfractionated Heparin in Non-ST-Segment Elevation Acute Coronary Syndromes." Journal of the American College of Cardiology (JACC), vol. 48, no. 7, 2006, p. 1346, https://doi.org/10.1016/j.jacc.2006.05.058.